A phase II, randomized, multicenter study evaluating the combination of lapatinib and vinorelbine in women with ErbB2 overexpressing metastatic breast cancer (Q37534928)
Jump to navigation
Jump to search
scientific article published on 09 January 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II, randomized, multicenter study evaluating the combination of lapatinib and vinorelbine in women with ErbB2 overexpressing metastatic breast cancer |
scientific article published on 09 January 2014 |
Statements
1 reference
A phase II, randomized, multicenter study evaluating the combination of lapatinib and vinorelbine in women with ErbB2 overexpressing metastatic breast cancer (English)
1 reference
Elzbieta Staroslawska
1 reference
Wolfgang Janni
1 reference
Tomasz Sarosiek
1 reference
Boguslawa Karaszewska
1 reference
Joanna Pikiel
1 reference
Piotr Potemski
1 reference
Christoph Salat
1 reference
Etienne Brain
1 reference
Christian Caglevic
1 reference
Kathryn Briggs
1 reference
Michelle Desilvio
1 reference
Luca Marini
1 reference
Christos Papadimitriou
1 reference
1 reference
9 January 2014
1 reference
1 reference
Identifiers
1 reference